Dopamine D1 receptor antagonist and application thereof
A dopamine and receptor technology, applied in the field of small molecule drugs, can solve the problems of weakened proliferation, decreased invasion ability and increased protein expression of glioma cells
Active Publication Date: 2021-03-09
TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
View PDF4 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Studies have shown that DRD1 protein is highly expressed in glioma tissue, and its expression can affect the growth of glioma cells. Dopamine D1 receptor antagonists can activate adenylate cyclase (adenylate cyclase, AC) to make its protei
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0020] Unless otherwise defined, the technical terms used in the following embodiments have the same meaning as commonly understood by those skilled in the art to which the present invention belongs. The test reagents used in the following examples, unless otherwise specified, are conventional biochemical reagents; the experimental methods, unless otherwise specified, are conventional methods.
[0021] The present invention relates to compound 2586-96-1 purchased from Chengdu Durst Biotechnology Co., Ltd.
[0022] The present invention will be described in detail below in conjunction with the embodiments and accompanying drawings.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The invention provides a dopamine D1 receptor antagonist and an application thereof, and relates to the field of medicinal chemistry. The invention relates to the field of medicine, in particular to adopamine D1 receptor antagonist shown in a structural formula (I), pharmaceutically acceptable salt of the dopamine D1 receptor antagonist, a pharmaceutical composition containing the dopamine D1 receptor antagonist, and an application of a compound medicine to preparation of medicines for treating or preventing related diseases or symptoms caused by high expression or over-high activity of a dopamine D1 receptor.
Description
technical field [0001] The invention belongs to the field of small molecule drugs, and in particular relates to a dopamine D1 receptor antagonist and its application. Background technique [0002] Dopamine receptors belong to the family of G protein-coupled receptors, and are receptors in organisms that function through membrane receptors. Dopamine receptors are widely distributed not only in the brain, but also throughout the human body. According to different binding forces with ligands, dopamine receptors are divided into five subtypes, namely D1, D2, D3, D4, D5, and can be divided into D1 and D2 families, wherein the D1 receptor family includes D1 and D5 subtypes , which can activate adenylate cyclase and increase intracellular cyclic adenosine monophosphate (cAMP) concentration; the D2 receptor family includes D2, D3 and D4 subtypes, which can inhibit adenylate cyclase and also interact with cells Associated with other 2nd messenger systems in the body, including acti...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more IPC IPC(8): C07D217/20A61K31/472A61P35/00
CPCC07D217/20A61P35/00
Inventor 林建平刘翠刘岯李金龙
Owner TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap